Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate |
2017-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-106947821-B |
titleOfInvention |
Biomarkers for diagnosis and treatment of colon adenocarcinoma |
abstract |
The invention discloses that COL18A1 gene can be used as molecular marker for early diagnosis of colon adenocarcinoma. Experiments prove that compared with normal tissues, the expression of the COL18A1 gene in colon adenocarcinoma tissues is obviously reduced, and overexpression experiments prove that the COL18A1 can influence the proliferation and apoptosis of colon adenocarcinoma cells. According to the research result of the invention, the medicine capable of promoting the expression of the COL18A1 gene can be developed, so that the prevention and treatment of colon adenocarcinoma in clinic can be realized. |
priorityDate |
2017-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |